The Technical AnalystExchange: OSE Sector: Healthcare Industry: Medical Devices
Medistim ASA Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
0.83% NOK181.50
Europe/Oslo / 30 apr 2024 @ 16:25
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 324.02 mill |
| EPS: | 5.61 |
| P/E: | 32.35 |
| Earnings Date: | Apr 25, 2024 |
| SharesOutstanding: | 18.31 mill |
| Avg Daily Volume: | 0.0058 mill |
| RATING 2024-04-30 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.56x |
| Company: PE 32.35 | sector: PE 57.61 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.79x |
| Company: PE 32.35 | industry: PE 40.82 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
NOK162.10 (-10.69%) NOK-19.40 |
| Date: 2024-05-01 |
| Expected Trading Range (DAY) |
|---|
|
NOK 175.41 - 187.59 ( +/- 3.36%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
-8.00
Sell
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | NOK181.50 (0.83% ) |
| Volume | 0.0020 mill |
| Avg. Vol. | 0.0058 mill |
| % of Avg. Vol | 34.52 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MEDI.OL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Mar 5 - 11:38 | buy | NOK201.00 | N/A | Active |
|---|
MEDI.OL
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.